Luminex to Host MAGPIX Road Shows Throughout the U.S. and Europe
By Luminex Corporation, PRNEMonday, September 27, 2010
MULTINATIONAL TOUR TO SHOWCASE CAPABILITIES OF NEW MULTIPLEXING INSTRUMENT
AUSTIN, Texas, September 28, 2010 - Luminex Corporation (Nasdaq: LMNX), today announced the initial dates and
locations for the MAGPIX(R) road show, a multinational tour designed to
showcase the recently-launched MAGPIX analytical instrument that is capable
of performing up to 50 tests on a single sample and providing nearly 5,000
data points in under an hour. The innovative format of the tour lets users
interact directly with the system and each other to enhance the sharing of a
broad set of applications.
(Logo: photos.prnewswire.com/prnh/20100104/LUMINEXLOGO) (Logo: www.newscom.com/cgi-bin/prnh/20100104/LUMINEXLOGO)
"We are very excited to launch our MAGPIX road show series to allow
researchers around the world to experience MAGPIX first hand," said Patrick
J. Balthrop, president and chief executive officer of Luminex. "This is an
opportunity for scientists across many disciplines to see, in person, how
MAGPIX easily allows them to harness the power of multiplexing and advance
their research."
The MAGPIX road show events will feature a presentation from a MAGPIX
user as well as an overview of the instrument and an explanatory animation of
the technology. EMD Millipore, the first distributor of the MAGPIX instrument
worldwide, also will be on site for demonstrations and to answer questions at
the U.S. events.
The following dates and locations have been scheduled for the MAGPIX road
show in Europe:
September 13 - Luminex Europe Office, Oosterhout, The Netherlands September 15 - Wageningen University, Wageningen, The Netherlands September 28 - October 1 - Exhibiting at The Instrument, The Sounds of Technology Conference, Amsterdam, The Netherlands October 5 - 7 - Exhibiting at the Biotechnica Conference, Hanover, Germany October 20-21 - Luminex Planet xMAP Multiplexing Congress, Vienna, Austria
The following dates and locations have been scheduled for the MAGPIX road
show in the U.S.:
November 2 - Longwood Galleria, Boston, MA November 3 - Middlesex Lounge, Cambridge, MA November 11 - The Bentley Reserve, San Francisco, CA November 13 - University Club, San Diego, CA, in conjunction with the Society for Neuroscience Annual Meeting December 13 - The Mask and Wig, Philadelphia, PA, in conjunction with the American Society for Cell Biology Annual Meeting
For more information on the entire MAGPIX road show, visit
www.luminexcorp.com/magpix.
Based on Luminex's xMAP(R) Technology, the easy-to-use MAGPIX instrument
is compact - comparable in size to a desktop computer - making it attractive
to smaller and lower-volume laboratories and institutions with limited
resources and bench space. The instrument provides fast, accurate and easily
reproducible results and can advance research across many disease states by
bringing many types of multiplexing applications to scientists. MAGPIX is
easy to install out of the box and weighs less than 40 lbs., approximately 18
kg, making it simple and affordable to ship and deploy anywhere in the world.
The instrument was designed to meet the needs of scientists who have not been
able to take advantage of the power of multiplexing because of resource or
space limitations.
For more information on MAGPIX, call +1-512-219-8020, or visit
www.luminexcorp.com/magpix.
About Luminex Corporation
Luminex Corporation develops, manufactures and markets proprietary
biological testing technologies with applications throughout the diagnostic
and life sciences industries. The Company's xMAP(R) multiplex solutions
include an open-architecture, multi-analyte technology platform that delivers
fast, accurate and cost-effective bioassay results to markets as diverse as
pharmaceutical drug discovery, clinical diagnostics and biomedical research,
including the genomics and proteomics markets. The Company's xMAP Technology
is sold worldwide and is already in use in leading clinical laboratories as
well as major pharmaceutical, diagnostic and biotechnology companies. Further
information on Luminex Corporation or xMAP Technology can be obtained at
www.luminexcorp.com.
Luminex Corporate Contact: Harriss T. Currie, Vice President, Finance and Chief Financial Officer +1-512-219-8020 hcurrie@luminexcorp.com Matthew Scalo Sr. Director of Investor Relations +1-512-219-8020 mscalo@luminexcorp.com Luminex Media Contact: Nicole Cottrill +1-615-327-7999 ncottrill@seigenthaler.com
Corporate, Harriss T. Currie, Vice President, Finance and Chief Financial Officer, hcurrie at luminexcorp.com, or Matthew Scalo, Sr. Director of Investor Relations, mscalo at luminexcorp.com, both of Luminex Corporation, +1-512-219-8020; or Media, Nicole Cottrill, +1-615-327-7999, ncottrill at seigenthaler.com, for Luminex Corporation
Tags: Austin, Europe, Luminex Corporation, September 28, texas